|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Gross profit (loss) | |||||
| Operating expenses: | |||||
| Research and development, net | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Financial expenses (income), net | |||||
| Net loss | |||||
| Basic net loss attributable to shareholders per Ordinary Share (in Dollars per share) | |||||
| Diluted net loss attributable to shareholders per Ordinary Share (in Dollars per share) | |||||
| Weighted average number of Ordinary Shares used in computing loss per Ordinary Share (in Shares) | |||||
Loading...